TriNetX Becomes Top Real-World Data Source Cited in Peer-Reviewed Research

TriNetX Becomes Leading Real-World Data Source in Research

In a significant milestone for health data science, TriNetX, driven by its vision of enhancing human health through connected data and intelligence, has established itself as the foremost cited real-world data source for peer-reviewed research. An analysis of records from PubMed indicates that as of August 27, 2025, TriNetX has garnered over 2,000 citations, thereby surpassing its nearest competitor by an impressive 1,300%.

This remarkable achievement highlights the vital role TriNetX plays in generating scientific evidence for clinical researchers, public health agencies, and health organizations across the globe. The citation numbers, a defining metric in academic and research communities, reveal a staggering rise from just 96 citations in 2021 to a projected 1,000 citations in 2025. This growth manifests strong confidence within the scientific community regarding the integrity and relevance of the data provided by TriNetX.

Jeffrey Brown, PhD, the Chief Scientific Officer at TriNetX, remarked, "Researchers require assurance that the data they utilize will withstand peer review and yield valuable insights. The recognition of TriNetX as the most cited real-world data source underscores our scalability and quality, as well as the trust that the global scientific community places in our platform to propel scientific advancement and enhance patient outcomes."

Furthermore, studies utilizing TriNetX's robust analytics platform have been featured in prestigious medical journals, including Nature Medicine and The Journal of Allergy and Clinical Immunology. These contributions are pivotal in shaping emerging standards for how real-world data (RWD) supports the development of drugs and vaccines, clinical evidence generation, and patient care effectiveness.

TriNetX’s citation surge corresponds directly to its rapid global network expansion via the TriNetX LIVE™ platform. From September 2024 to September 2025, both health organizations and patient data represented in the platform have reached unprecedented levels. Notably, there was a staggering growth of 70% in Latin America and a 31% increase in the Asia-Pacific region, emphasizing the burgeoning demand for data-driven healthcare solutions.

Steve Kundrot, Chief Operating Officer of TriNetX, stated, "Our network's accelerated growth reflects the global interests of our clients and partners, spanning drug discovery, clinical trial design, comparative effectiveness, and health service delivery. The pace of integrating and expanding patient data across healthcare organizations strengthens the power of real-world evidence worldwide, making TriNetX a reliable foundation for credible research."

TriNetX operates the largest federated real-world data network, collaborating with healthcare professionals to harness intelligence that stimulates innovation across the healthcare ecosystem. Through its self-service platform, adhering to HIPAA, GDPR, and LGPD standards, TriNetX facilitates improvements in clinical trial protocol designs, optimizes study operations, refines safety signals, and augments real-world evidence generation.

For further information, visit TriNetX Datasets Analytics. To learn more about TriNetX and its contributions to health data science, follow them on LinkedIn or visit www.trinetx.com.